Trp53 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Trp53 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC4 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC4AP Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC4AP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC5 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC6 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPC7 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM4 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM5 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM6 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM7 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPM8 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPM8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPS1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV1 antagonist 6 (compound 51) is a mode-selective antagonist for transient receptor potential vanilloid member 1 (TRPV1), which shows antagonism with IC50 of 2.85 nM to capsaicin activation and 28.48 % inhibition against proton activation at a 3 µM concentration[1].

TRPV1 antagonist 7 (Compound 36) is a selective TRPV1 antagonist that effectively blocks capsaicin activation (IC50=2.31 nM). TRPV1 antagonist 7 can be used in analgesic research[1].

TRPV1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV4 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV5 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRPV6 Human Pre-designed siRNA Set A contains three designed siRNAs for TRPV6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRRAP Human Pre-designed siRNA Set A contains three designed siRNAs for TRRAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TrxR1-IN-B19 (GO-Y015) (Compound B19) is a Curcumin (HY-N0005) derivative and colvalent TrxR1 inhibitor. TrxR1-IN-B19 inhibits TrxR1 enzyme activity to elevate oxidative stress, and then induce ROS-mediated ER Stress and mitochondrial dysfunction, subsequently resulting in cell cycle arrest and apoptosis[1].

TS-24 is an inhibitor for cathepsin S, with an IC50 of 4.3 μM. TS-24 exhibits radiosensitizing activity in wild type breast cancer susceptibility gene 1 (BRCA1) and in TNBC xenograft mice model, through induction of apoptosis[1].

TSACC Human Pre-designed siRNA Set A contains three designed siRNAs for TSACC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TSBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC1 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC2 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC22D1 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC22D1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC22D2 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC22D2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC22D3 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC22D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSC22D4 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC22D4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TSEN15 Human Pre-designed siRNA Set A contains three designed siRNAs for TSEN15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.